glp 1 in breastfeeding Ozempic, Wegovy & Breastfeeding: Are GLP-1 Drugs Safe for Nursing Moms? — Bonnie Knows Breast GLP-1s and Breastfeeding — Bridges

1 Beyond diabetes and obesity Cardiovascular disease In March 2024, the US Food and Drug Administration (FDA) approved Wegovy (semaglutide) for adults with cardiovascular disease (CVD) and either obesity and overweight to reduce the risk of cardiovascular death, heart attack, and stroke

A systematic review of 23 clinical and preclinical studies confirmed GLP-1R expression on monocytes, macrophages, and effector T cells, underscoring the receptors role in systemic immunomodulation [383]

The International Foundation of Employee Benefit Plans has tracked this since October 2023, and the 2026 data reveals a clear pattern: coverage for diabetes keeps rising, but coverage for weight loss has stalled

I look forward to my next visit

What are they called